Different early effets of tyrphostin AG957 and geldanamycins on mitogen-activated protein kinase and p120cbl phosphorylation in anti CD-3-stimulated T-lymphoblasts.
Losiewicz MD, Kaur G, Sausville EA.
Losiewicz MD, et al. Among authors: sausville ea.
Biochem Pharmacol. 1999 Feb 1;57(3):281-9. doi: 10.1016/s0006-2952(98)00293-7.
Biochem Pharmacol. 1999.
PMID: 9890555
AG957, a tyrphostin tyrosine kinase inhibitor, has been shown previously to inhibit p210(bcr-abl) phosphorylation with concurrent inhibition of p210(bcr-abl)-expressing K562 cell growth (Kaur G and Sausville EA, Anticancer Drugs 7: 815-824, 1996). To assess the spec …
AG957, a tyrphostin tyrosine kinase inhibitor, has been shown previously to inhibit p210(bcr-abl) phosphorylation with concurrent inhibition …